Benzo[Def]Chrysene

Benzo[Def]Chrysene

SCHEMBL29352452

c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 1.00
ERBB2 P04626 1/20 1.00
FYN P06241 1/20 1.00
MAOA P21397 1/20 1.00
ACHE P22303 1/20 1.00
AHR P35869 1/20 1.00
ALDH1A1 P00352 7/20 0.65
HSD17B10 Q99714 7/20 0.65
HPGD P15428 5/20 0.65
THRB P10828 1/20 0.65
CYP1B1 Q16678 3/20 0.52
HIF1A Q16665 2/20 0.52
TSHR P16473 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
MAPK1 P28482 1/20 0.52
CASP1 P29466 1/20 0.52
HPRT1 P00492 3/20 0.50
CYP3A4 P08684 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP1A1 P04798 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzo[Def]Chrysene SCHEMBL17114373 1.00 CYP1A2 (1.00) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL24019 1.00 CYP1A2 (1.00) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL29826740 1.00 CYP1A2 (1.00) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL30358490 1.00 CYP1A2 (1.00) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL29407951 1.00 CYP1A2 (1.00) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL23414475 1.00 CYP1A2 (1.00) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL11393448 0.98 CYP1A2 (0.96) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL4852478 0.98 CYP1A2 (0.96) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL5473588 0.98 CYP1A2 (0.96) CYP1A2ERBB2FYNMAOAACHE
Benzo[Def]Chrysene SCHEMBL28698813 0.98 CYP1A2 (0.96) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070124-A Composition comprising triglycerides 赢创运营有限公司 2026-05-19 CN claimed
US-12622925-B2 Edible enterosorbents used to mitigate acute exposures to ingestible environmental toxins following outbreaks, natural disasters and emergencies NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2026-05-12 US claimed
US-12619005-B2 Optical film with improved optical properties, display apparatus comprising same, and manufacturing method therefor KOLON INDUSTRIES, INC. (KR) 2026-05-05 US claimed
WO-2025264111-A1 A PROCESS FOR THE USE OF GLYOXYLIC AROMATIC CONDENSATES AS RE-TANNING AGENTS STAHL INTERNATIONAL B.V. (NL) 2025-12-26 WO claimed
US-20250376691-A1 FLOTATION OF CULTURED EMBRYO EXPLANTS FOR IMPROVED PLANT REGENERATION EFFICIENCY MONSANTO TECHNOLOGY LLC (US) 2025-12-11 US claimed
US-20250374951-A1 GROUND TOBACCO COMPOSITION NICOVENTURES TRADING LTD (GB) 2025-12-11 US claimed
US-20250360493-A1 TIO2-CQDS NANOFLOWER PHOTOCATALYST, PHOTOCATALYTIC THIN FILM AND APPLICATION UNIV HEFEI TECHNOLOGY (CN) 2025-11-27 US claimed
WO-2025244608-A1 HAZELNUT MICROPROPAGATION METHOD TARLA BITKILERI MERKEZ ARASTIRMA ENSTITUSU MUDURLUGU (TR) 2025-11-27 WO claimed
WO-2025214989-A1 METHOD FOR PRODUCING A NON-HAZARDOUS PROCESS OIL, AND USE THEREOF HANSEN & ROSENTHAL GMBH & CO. KG (DE) 2025-10-16 WO claimed
US-12440871-B2 Monitoring device for detecting at least one substance component in comminuted materials, conveying system for comminuted materials and method for monitoring comminuted materials Dieffenbacher GmbH Maschinen—und Anlagenbau (DE) 2025-10-14 US claimed
US-11266086-B2 Efficient plant transformation method WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2022-03-08 US claimed
CN-114126400-A Cocoa cell suspension protocol 马斯公司 2022-03-01 CN claimed
CN-114105348-A Device and method for treating benzo (a) pyrene in coking wastewater 中国石油化工股份有限公司 2022-03-01 CN claimed
CN-109437159-B Preparation method of graphene-carbon nanotube double-component suspension 西北工业大学 2022-03-01 CN claimed
CN-114105347-A System and method for treating wastewater containing benzo (a) pyrene 中国石油化工股份有限公司 2022-03-01 CN claimed
EP-3956081-A1 SYSTEM AND METHOD FOR BIOREMEDIATION OF SOIL The Trustees of Columbia University in the City of New York (US) 2022-02-23 EP claimed
WO-2022034604-A1 A PROCESS OF PREPARATION OF NOVEL GROWTH MEDIUM FOR EFFECTIVE DEVELOPMENT OF IN VITRO SEEDLINGS, PLANTLETS AND ROOT OF TERMINALIA TOMENTOSA AND PRODUCT THEREOF VASAMSETTI MS ASHA KRISHNA (IN) 2022-02-17 WO claimed
EP-3948288-A1 METHOD FOR DETECTING OR MONITORING THE DEVELOPMENT OF A CHRONIC PROLIFERATIVE DISEASE BY IMMUNOASSAY PolyNeuroS (FR) 2022-02-09 EP claimed
US-20220032350-A1 SYSTEM AND METHOD FOR BIOREMEDIATION OF SOIL THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2022-02-03 US claimed
CN-113980066-A Method for removing benzopyrene in flax extract 西安天一生物技术股份有限公司 2022-01-28 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622925-B2 Edible enterosorbents used to mitigate acute exposures to ingestible environmental toxins following outbreaks, natural disasters and emergencies FABP2, LCT, DDT CYP1A2 2950/4885ERBB2 3098/4885FYN 4341/4885
US-12619005-B2 Optical film with improved optical properties, display apparatus comprising same, and manufacturing method therefor SETDB1, TRAFD1, RFC5 CYP1A2 4801/4885ERBB2 1923/4885FYN 2797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.